Pharma Journalist - Page 884 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

TrialScope Launches Second Global Clinical Trial Disclosure Maturity

miRagen Therapeutics’s MRG- 106 receives EU Orphan Medicinal Product Designation

Sun Pharma announces that US FDA Filing acceptance of BLA for Tildrakizumab

KBI Biopharma Invests $30M for Expansion projects of Durham and Boulder sites

Selexis SA and OSE Immunotherapeutics signs agreement for development of OSE’s interleukin receptor 7 antagonist

Pierre Fabre acquires Igenica Biotherapeutics Immuno-Oncology

LSNE Contract Manufacturing and Selecta Biosciences signs manufacturing supply agreement

Intellipharma reports Par Pharma additional strengths launch of generic Focalin XR

Hebron Technology wins design and implementation project Bid at Tianjin Chas esun

Astrazeneca’s Bydureon EXSCEL trial meets primary safety objective in type-2 diabetes patients